BCIS-1: Pre-Procedure Elective IABP Use in High-Risk Patients Reduces Mortality by 34% at 5 Years

Start Page: 
42
End page: 
44
Author(s): 

Cath Lab Digest talks with trial co-investigator Divaka Perera, MA, MD, MRCP, Cardiovascular Division, Rayne Institute, St Thomas’ Hospital Campus, King’s College London, London, United Kingdom

Bookmark/Search this post with
image description image description Other Clinical Trial Update Articles




  


  
Post new comment


  



 
 




 
 




 
 



  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
More information about formatting options




Image CAPTCHA

 
 
 
Enter the characters shown in the image.